C4 Therapeutics, Inc.
€3.207
EUR
Last updated on --.
24h volume2.49M
24h highest3.4099 EUR
24h lowest3.0272 EUR
24h Price movement+6.88%
CCCC recent prices
24 Hours
+6.88%+€0.2064
30 days
+36.91%+€0.8729
60 days
+60.21%+€1.216
90 days
+39.44%+€0.9159
Key data
Previous close3.0014 EUR
Market cap311.89M EUR
Volume2.49M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.80840 EUR
Net income (FY)-89.27M EUR
Revenue (FY)29.98M EUR
Last report date12 May 2026
About C4 Therapeutics, Inc.
HeadquartersWATERTOWN
Employees (FY)104.00
Revenue per employee (FY)288.27K EUR
Net income per employee (FY)-858.35K EUR
Listed onNasdaq
CCCC conversion tables
 |  |
|---|---|
| 0.5 CCCC | 1.603 EUR |
| 1 CCCC | 3.207 EUR |
| 5 CCCC | 16.03 EUR |
| 10 CCCC | 32.07 EUR |
| |
|---|---|
| 0.5 EUR | 0.15587 CCCC |
| 1 EUR | 0.31174 CCCC |
| 5 EUR | 1.558 CCCC |
| 10 EUR | 3.117 CCCC |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CCCC is trading at €3.207, +6.88% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CCCC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CCCC is currently trading at €3.207, +6.88% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CCCC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CCCC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CCCC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CCCC's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
C4 Therapeutics, Inc.'s market cap is currently 311.89M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.49M
24h highest3.4099 EUR
24h lowest3.0272 EUR
24h Price movement+6.88%
Start trade with CCCC Perpetual
Sign up to trade